It is appropriate to clarify the genetic status of apparently asymptomatic older and younger sibs of an individual with genetically confirmed MAP by molecular genetic testing of the MUTYH pathogenic variants identified in the proband in order to reduce morbidity and mortality in those who would benefit from appropriate surveillance, early diagnosis, and treatment.

See Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes.
